Zydus Lifesciences shares rose over 6% after strong Q4FY26 earnings, reporting a 14.6% increase in net profit to ₹1,592.9 crore. Revenue grew to ₹7,587 crore, driven by the consumer wellness segment. The board approved a ₹1,100 crore share buyback and a Re 1 dividend.
Recent Posts
- LinkedIn sacks over 600 employees across roles, as Meta begins AI-driven layoffs: Report
- Samvardhana Motherson Q4 Results LIVE: Revenue, profit likely to rise in double-digits; all eyes on dividend; stock flat
- Vodafone Idea, Fineotex Chemical, Ola Electric, Apollo Micro Systems among most traded stocks on NSE today, 20 May 2026
- Hindalco share price jumps 4% after Novelis posts Q4 earnings 2026; check results date for the Aditya Birla Group stock
- 950% rally in 5 years! BLS International Services shares jump 9.5% after Q4 results 2026. Do you own?